Recently, Autobio's wholly-owned subsidiary, Autobio Laboratory Instruments (Zhengzhou) Co., Ltd., was granted an international invention patent (EP3916077) by the European Patent Office for its Fully Automated Microbial Identification and Drug Sensitivity Analysis System. This milestone not only strengthens the company's international intellectual property protection but also underscores its innovative strength in microbiological testing.
In recent years, the widespread use of antibacterial drugs has fueled a surge in drug-resistant strains, posing significant challenges to clinical treatment. The irrational use of antibiotics has led to soaring treatment failure rates and increased side effects. As a result, drug susceptibility testing has become critical in preventing and treating infectious diseases effectively.
The AutoMic-i600 is a fully automated and intelligent instrument developed by Autobio after years of research. With its standout features——like automatic sample addition, intelligent identification, automated incubation, and precise interpretation——it directly addresses current clinical needs and pain points. This cutting-edge system enables rapid, accurate microbial identification and in vitro drug susceptibility testing, achieving a domestic advanced level of performance.
The AutoMic-i600 integrates sample addition, incubation, and detection into a seamless automated process, reducing manual workload and improving efficiency.
Utilizing colorimetric and turbidimetric joint determination, 4-wavelength simultaneous detection, and timed uninterrupted automatic interpretation, the system incorporates an AI-powered algorithm model for highly accurate results.
Equipped with a 64-card high-throughput incubation chamber, it caters to the testing demands of users at all levels.
The system automatically identifies reagent and plate information and seamlessly connects to microbiology laboratory management systems and LIS (Laboratory Information Systems), enhancing workflow efficiency.
Global Impact and Patent Significance
The launch of the AutoMic-i600 fully automatic microbiological identification and drug susceptibility analyser has revolutionized the final, most crucial step in clinical microbiological testing. This innovation not only enriches Autobio's microbiological testing product line but also drives its expansion into global markets, including Europe, South America, Africa, the Middle East, and Southeast Asia. Securing this international invention patent lays a robust foundation for the worldwide promotion of the AutoMic-i600
Address: NO.87 Jingbei Yi Rd, National Eco＆Tech Zone, Zhengzhou, China
Email: info@autobio-diagnostics.com Tel: +86-371-6200-7036
Autobio Copyright Reserved for ICP 18006568. All Rights Reserved.
Select Market or Language
